Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB2002584	拉替拉韦钾干混悬剂	raltegravir potassium	Suspension	Chemical Drugs	Supplementary Application	2020-12-16	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd;Merck Sharp & Dohme Corp;Patheon Pharmaceuticals Inc	Filed	2020-12-25	view
JXHS1700019	拉替拉韦钾干混悬剂	raltegravir potassium	Suspension	Chemical Drugs(5.1)	Import Drug Application	2017-04-10	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd;Merck Sharp & Dohme Corp;Patheon Pharmaceuticals Inc	Certificate Issued	2018-04-24	view
JXHL1500150	拉替拉韦钾干混悬剂	raltegravir potassium	Suspension	Chemical Drugs	Import Drug Application	2015-07-01	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd;Merck Sharp & Dohme Corp	Certificate Issued	2016-11-01	view